TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Swedish Orphan Biovitrum AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
30,739
|
18,618
|
18,315 |
Financial expenses |
7
|
1
|
0 |
Earnings before taxes |
9,306
|
5,370
|
5,490 |
Total assets |
40,683
|
31,123
|
26,150 |
Current assets |
40,668
|
31,078
|
26,068 |
Current liabilities |
8,089
|
3,972
|
3,865 |
Equity capital |
32,595
|
27,150
|
22,285 |
- share capital |
99
|
106
|
103 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
80.1%
|
87.2%
|
85.2% |
Turnover per employee | |||
Profit as a percentage of turnover |
30.3%
|
28.8%
|
30.0% |
Return on assets (ROA) |
22.9%
|
17.3%
|
21.0% |
Current ratio |
502.8%
|
782.4%
|
674.5% |
Return on equity (ROE) |
28.6%
|
19.8%
|
24.6% |
Change turnover |
13,355
|
-264
|
-830 |
Change turnover % |
77%
|
-1%
|
-4% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.